Article
Metastatic melanoma treatment: Combining old and new therapies.
Critical reviews in oncology/hematology - 1 Feb 2016
Davey Ryan J, van der Westhuizen Andre, Bowden Nikola A
Abstract excerpt
Metastatic melanoma is an aggressive form of cancer characterised by poor prognosis and a complex etiology. Until 2010, the treatment options for metastatic melanoma were very limited. Largely ineffective dacarbazine, temozolamide or fotemustine were the only agents in use for 35 years. In recent years, the development of molecularly targeted inhibitors in parallel with the development of checkpoint inhibition...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
